FITB vs IART · P/E 17, rev $3.37B vs rev $1.64B
Fifth Third Bancorp (FITB) versus Integra LifeSciences Holdings (IART) — a side-by-side from cached financials, not a winner call.
Fifth Third Bancorp (FITB) is a banks - regional company listed on US.
Integra LifeSciences Holdings (IART) is a medical devices company listed on US.
Latest reported FITB revenue for 2026-06-30 was $3.37B. Net income was $801.0M. Revenue was up 13.5% from 2026-03-31 to 2026-06-30. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
Latest reported IART revenue for 2025-12-31 was $1.64B. Net income was -$516.5M. IART currently screens at market cap $1.32B.
FITB currently screens at market cap $45.25B and trailing P/E 16.8. IART currently screens at market cap $1.32B.
Not investment advice. Open the FITB and IART stock pages for the full models.
Not investment advice.